Form 4: Pacific Biosciences Executive Sells Shares to Cover Tax Obligations

Mark Van Oene, Chief Operating Officer of Pacific Biosciences, sold 34,405 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On January 10, 2025, Mark Van Oene, the Chief Operating Officer of Pacific Biosciences, sold 34,405 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $2.034, with individual prices ranging from $1.99 to $2.09 per share.
• Following the transaction, Van Oene beneficially owns 1,597,454 shares of Pacific Biosciences stock, which includes 1,044 shares purchased under the company's 2010 Employee Stock Purchase Plan on September 3, 2024.

Sentiment

Score: 5

Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal occurrence and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine Form 4 filing, reflecting an executive's stock sale to cover tax obligations, a common practice in publicly traded companies.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.

Key Dates